Menu
iPMI Magazine Is Proudly Sponsored By:
For a healthier journey.

iPMI Magazine Has Moved

iPMI Magazine successfully rebranded to iPMI Global in 2023 and has moved to a new home on the internet. To visit the brand new international private medical insurance business intelligence platform, please go to www.ipmiglobal.com

XVIII - The Centre for Advanced Screening Opens Its Doors

XVIII – The Centre for Advanced Screening where senior executives can undergo the most sophisticated and detailed health screening has opened in Devonshire Street, London, 

The brainchild of fifteen of the world’s leading doctors, the XVIII programme targets the six of the biggest killer diseases of modern times: bowel cancer, breast cancer, cardiovascular disease, lung cancer, pelvic cancers and prostate cancer.  Early detection of these conditions can save lives. 

XVIII goes beyond traditional well man and well women tests by combining a thorough assessment of an individual’s risk factors with the very latest diagnostic technology, all of which exists under the same roof.  The programme is intended to guide very time-pressured men and women at the top of their professions towards a personal programme of lifetime management of their risk of future disease.   Clients include chairmen and chief executives of major organisations, leading entrepreneurs for whom life brings with it high levels of pressure and stress or simply people seeking the most thorough advanced screening available. 

Apart from conventional and state of the art scanning investigations, XVIII uses a number of innovative tests.  For example, cardiac disease is still the UK’s biggest killer and the centre carries out the newly developed online calculator of cardiovascular risk – “Heart Age” - faced by individuals. 

All tests with abnormal results are interpreted by world renowned specialists who themselves are driving change and innovation and thereby enhancing the reputation of London as a world class centre of medical excellence. 

The chair of the programme’s clinical board is Professor Roger Kirby, a pioneer in new treatments for prostate cancer and other urological conditions.  Professor Kirby is Founder and  Medical Director of The Prostate Centre, London and former Head of Urology and Co-Director of Postgraduate Medical Education at St George’s Hospital, London. 

“We all share a common obsession.  Passionately believing that early detection of disease saves lives, we know that many currently available health screens fall well short of achieving their aim - or rather your aim, since it is your health and your future at stake.” 

“At XVIII we have access to game changing technology which gives us dramatically improved means of detecting killer diseases – while at the same time reducing or eliminating the risks of the tests themselves.” 

“It is this that has brought us together to offer clients the opportunity to learn more about their health and to take control and manage their health into the future.  Our very personalised service is simply not available elsewhere.” 

Read more...
Subscribe to this RSS feed